[Refractory subacute cutaneous lupus erythematosus with a response to efalizumab].
Guillermo
N
N
Peñate
Y
Y
Hernández-Machín
B
B
Borrego
L
L
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D006801:Humans; D008178:Lupus Erythematosus, Cutaneous / Q000188:drug therapy*; D008875:Middle Aged; D012074:Remission Induction
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C472181:efalizumab